Shigeru Ohmori
- Pharmacology top 0.5%
- Hepatology top 1%
- Molecular Biology
- Oncology top 10%
- Surgery top 10%
- Co-authors
- Katsuya ShirakiTakeshi NakanoTakahisa SakaiMitsukazu KitadaKazushi SugimotoHidekazu InoueKazumoto MurataHiroshi Okano
- Topics
- Pharmacogenetics and Drug Metabolism (44 papers)Liver Disease Diagnosis and Treatment (17 papers)Drug Transport and Resistance Mechanisms (16 papers)
- Journals
- GastroenterologyPLoS ONEBiochemistry
- Partner nations
- JapanUnited StatesCameroon
In The Last Decade
Shigeru Ohmori
131 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 117
- Pharmacology 648
- Hepatology 612
- Molecular Biology 598
- Oncology 428
- Surgery 411
Countries citing papers authored by Shigeru Ohmori
This map shows the geographic impact of Shigeru Ohmori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigeru Ohmori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigeru Ohmori more than expected).
Fields of papers citing papers by Shigeru Ohmori
This network shows the impact of papers produced by Shigeru Ohmori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigeru Ohmori. The network helps show where Shigeru Ohmori may publish in the future.
Co-authorship network of co-authors of Shigeru Ohmori
This figure shows the co-authorship network connecting the top 25 collaborators of Shigeru Ohmori. A scholar is included among the top collaborators of Shigeru Ohmori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigeru Ohmori. Shigeru Ohmori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Detecting Coadministered Drugs that Affect the Incidence of Long QT Syndrome Associated with Fluoroquinolone Antibiotics Using a Spontaneous Reporting System | 2 |
| 2 | [Desensitization Therapy for Osimertinib in Patients Who Developed Toxic Erythema - Two Case Reports]. | 1 |
| 3 | 4 | |
| 4 | 19 | |
| 5 | 6 | |
| 6 | 20 | |
| 7 | 1 | |
| 8 | 21 | |
| 9 | 3 | |
| 10 | 64 | |
| 11 | 1 | |
| 12 | 0 | |
| 13 | 159 | |
| 14 | Comparison of screening methods for hepatocellular carcinomas in patients with cirrhosis. | 5 |
| 15 | 34 | |
| 16 | 1 | |
| 17 | 61 | |
| 18 | 3 | |
| 19 | 9 | |
| 20 | CHARACTERIZATION AND PURIFICATION OF VARIOUS CARBOXYLESTERASE ISOZYMES FROM RAT LIVER MICROSOME | 1 |
About Shigeru Ohmori
Shigeru Ohmori is a scholar working on Pharmacology, Hepatology and Biochemistry, having authored 132 papers that have together received 2.3k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (44 papers), Liver Disease Diagnosis and Treatment (17 papers) and Drug Transport and Resistance Mechanisms (16 papers). The work is most often cited by research in Hepatology (612 citations), Pharmacology (648 citations) and Anesthesiology and Pain Medicine (92 citations). Shigeru Ohmori has collaborated with scholars based in Japan, United States and Cameroon. Frequent co-authors include Katsuya Shiraki, Takeshi Nakano, Takahisa Sakai, Mitsukazu Kitada, Kazushi Sugimoto, Hidekazu Inoue, Kazumoto Murata, Hiroshi Okano, Masatoshi Deguchi and Tamihide Matsunaga. Their work appears in journals such as Gastroenterology, PLoS ONE and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.